A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification
Line S. Tarpgaard, Camilla Qvortrup, Sune Boris Nygård, Signe Lykke Nielsen, Diana R. Andersen, Niels Frank Jensen, Jan Stenvang, Sönke Detlefsen, Nils Brünner, Per Pfeiffer
21Citations
(Scopus)
73Downloads
(Pure)
Fingerprint
Dive into the research topics of 'A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification'. Together they form a unique fingerprint.